Peptide pull-downs were performed on NB1 cell lysate [prepared using lysis buffer containing 50 mM tris (pH 8.5), 150 mM NaCl, 10 mM potassium chloride, 0.1% Triton X-100, and 0.5 mM dithiothreitol (DTT) with the addition of 5 mM β-glycerophosphate, 5 mM sodium fluoride, 1 mM sodium orthovanadate, and 1 cOmplete inhibitor cocktail tablet per 10 ml (Roche)], from DMSO- and LDK378-treated cells using biotinylated peptides; phosphotyrosine-containing peptides or the corresponding nonphosphorylated version (fig. S1C). Peptides included the following phosphotyrosines (±6 amino acids flanking the indicated phosphotyrosine residues) from ALK (Tyr1078, Tyr1092, Tyr1096, Tyr1131, Tyr1278, Tyr1283, Tyr1283, Tyr1359, Tyr1507, Tyr1584, and Tyr1604) and from IRS2 (Tyr675, Tyr742, and Tyr978), including the nonphosphorylated counter peptide synthesized by Intavis and coupled to Sepharose-streptavidin beads (GE Healthcare) in a buffer containing 50 mM tris (pH 8.5), 150 mM NaCl, and 0.1% NP-40. Pull-downs (1 mg of cell lysate per pull-down), elution, and on-bead trypsin digestion were carried out in 96-well multiscreen filter plates essentially as described by Eberl et al. (72).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.